![Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial - Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial -](https://www.thelancet.com/cms/attachment/a7bef0f9-4be9-488a-8add-a42a95e110b0/gr1.gif)
Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial -
Enzyme-Responsive Double-Locked Photodynamic Molecular Beacon for Targeted Photodynamic Anticancer Therapy | Journal of the American Chemical Society
![Nanomaterials | Free Full-Text | Bead-Immobilized Multimodal Molecular Beacon-Equipped DNA Machinery for Specific RNA Target Detection: A Prototypical Molecular Nanobiosensor Nanomaterials | Free Full-Text | Bead-Immobilized Multimodal Molecular Beacon-Equipped DNA Machinery for Specific RNA Target Detection: A Prototypical Molecular Nanobiosensor](https://www.mdpi.com/nanomaterials/nanomaterials-11-01617/article_deploy/html/images/nanomaterials-11-01617-g001.png)
Nanomaterials | Free Full-Text | Bead-Immobilized Multimodal Molecular Beacon-Equipped DNA Machinery for Specific RNA Target Detection: A Prototypical Molecular Nanobiosensor
![A fiber optoacoustic guide with augmented reality for precision breast-conserving surgery | Light: Science & Applications A fiber optoacoustic guide with augmented reality for precision breast-conserving surgery | Light: Science & Applications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41377-018-0006-0/MediaObjects/41377_2018_6_Fig1_HTML.jpg)